Heineken Misses 3Q Revenue on Sluggish Sales Growth

The video covers Heineken's third-quarter revenue miss and sluggish sales due to a volatile global environment and poor weather. It also discusses leadership changes at Total, with Patrick Giuliani confirmed as the new CEO following Christophe de Margerie's death. Additionally, Johnson & Johnson's efforts to develop an Ebola vaccine are highlighted, with plans to produce 250,000 doses for clinical trials and 1 million doses next year.

What challenges did Heineken face in the third quarter?

How many people have been killed by Ebola in West Africa?